Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Eliron-LC is an oral nutraceutical combination product developed and marketed by Elliott Labs in India. It is formulated as a tablet containing a synergistic blend of Omega-3 fatty acids (150 mg), Ubiquinol/Coenzyme Q10 (100 mg), L-Carnitine L-Tartrate (100 mg), Wheat Germ Oil (25 mg), Lycopene (5 mg), and Piperine (5 mg). The supplement is intended to provide cardiovascular and antioxidant support. Ubiquinol and lycopene serve as potent antioxidants to mitigate oxidative stress, while Omega-3 fatty acids and L-carnitine support heart health and cellular energy metabolism. Piperine is included to enhance the bioavailability of the other active ingredients. It is commercially available in India for general wellness and nutritional support.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Eliron-LC.